Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies

ABSTRACT Influenza virus neuraminidase (NA) has been under intense study recently as a vaccine antigen, yet there remain unanswered questions regarding the immune response directed toward NA. Antibodies (Abs) that can inhibit NA activity have been shown to aid in the control of disease caused by inf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. R. Job, T. Ysenbaert, A. Smet, A. Van Hecke, L. Meuris, H. Kleanthous, X. Saelens, T. U. Vogel
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://doaj.org/article/7d9069626bfa4f5f9bd82345c4070ea2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7d9069626bfa4f5f9bd82345c4070ea2
record_format dspace
spelling oai:doaj.org-article:7d9069626bfa4f5f9bd82345c4070ea22021-11-15T15:59:40ZFcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies10.1128/mBio.01667-192150-7511https://doaj.org/article/7d9069626bfa4f5f9bd82345c4070ea22019-10-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01667-19https://doaj.org/toc/2150-7511ABSTRACT Influenza virus neuraminidase (NA) has been under intense study recently as a vaccine antigen, yet there remain unanswered questions regarding the immune response directed toward NA. Antibodies (Abs) that can inhibit NA activity have been shown to aid in the control of disease caused by influenza virus infection in humans and animal models, yet how and if interactions between the Fc portion of anti-NA Abs and Fcγ receptors (FcγR) contribute to protection has not yet been extensively studied. Herein, we show that poly- and monoclonal anti-NA IgG antibodies with NA inhibitory activity can control A(H1N1)pdm09 infection in the absence of FcγRs, but FcγR interaction aided in viral clearance from the lungs. In contrast, a mouse-human chimeric anti-NA IgG1 that was incapable of mediating NA inhibition (NI) solely relied on FcγR interaction to protect transgenic mice (with a humanized FcγR compartment) against A(H1N1)pdm09 infection. As such, this study suggests that NA-specific antibodies contribute to protection against influenza A virus infection even in the absence of NI activity and supports protection through multiple effector mechanisms. IMPORTANCE There is a pressing need for next-generation influenza vaccine strategies that are better able to manage antigenic drift and the cocirculation of multiple drift variants and that consistently improve vaccine effectiveness. Influenza virus NA is a key target antigen as a component of a next-generation vaccine in the influenza field, with evidence for a role in protective immunity in humans. However, mechanisms of protection provided by antibodies directed to NA remain largely unexplored. Herein, we show that antibody Fc interaction with Fcγ receptors (FcγRs) expressed on effector cells contributes to viral control in a murine model of influenza. Importantly, a chimeric mouse-human IgG1 with no direct antiviral activity was demonstrated to solely rely on FcγRs to protect mice from disease. Therefore, antibodies without NA enzymatic inhibitory activity may also play a role in controlling influenza viruses and should be of consideration when designing NA-based vaccines and assessing immunogenicity.E. R. JobT. YsenbaertA. SmetA. Van HeckeL. MeurisH. KleanthousX. SaelensT. U. VogelAmerican Society for MicrobiologyarticleinfluenzaneuraminidaseFcγ receptorantibodiesinfluenza vaccinesMicrobiologyQR1-502ENmBio, Vol 10, Iss 5 (2019)
institution DOAJ
collection DOAJ
language EN
topic influenza
neuraminidase
Fcγ receptor
antibodies
influenza vaccines
Microbiology
QR1-502
spellingShingle influenza
neuraminidase
Fcγ receptor
antibodies
influenza vaccines
Microbiology
QR1-502
E. R. Job
T. Ysenbaert
A. Smet
A. Van Hecke
L. Meuris
H. Kleanthous
X. Saelens
T. U. Vogel
Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
description ABSTRACT Influenza virus neuraminidase (NA) has been under intense study recently as a vaccine antigen, yet there remain unanswered questions regarding the immune response directed toward NA. Antibodies (Abs) that can inhibit NA activity have been shown to aid in the control of disease caused by influenza virus infection in humans and animal models, yet how and if interactions between the Fc portion of anti-NA Abs and Fcγ receptors (FcγR) contribute to protection has not yet been extensively studied. Herein, we show that poly- and monoclonal anti-NA IgG antibodies with NA inhibitory activity can control A(H1N1)pdm09 infection in the absence of FcγRs, but FcγR interaction aided in viral clearance from the lungs. In contrast, a mouse-human chimeric anti-NA IgG1 that was incapable of mediating NA inhibition (NI) solely relied on FcγR interaction to protect transgenic mice (with a humanized FcγR compartment) against A(H1N1)pdm09 infection. As such, this study suggests that NA-specific antibodies contribute to protection against influenza A virus infection even in the absence of NI activity and supports protection through multiple effector mechanisms. IMPORTANCE There is a pressing need for next-generation influenza vaccine strategies that are better able to manage antigenic drift and the cocirculation of multiple drift variants and that consistently improve vaccine effectiveness. Influenza virus NA is a key target antigen as a component of a next-generation vaccine in the influenza field, with evidence for a role in protective immunity in humans. However, mechanisms of protection provided by antibodies directed to NA remain largely unexplored. Herein, we show that antibody Fc interaction with Fcγ receptors (FcγRs) expressed on effector cells contributes to viral control in a murine model of influenza. Importantly, a chimeric mouse-human IgG1 with no direct antiviral activity was demonstrated to solely rely on FcγRs to protect mice from disease. Therefore, antibodies without NA enzymatic inhibitory activity may also play a role in controlling influenza viruses and should be of consideration when designing NA-based vaccines and assessing immunogenicity.
format article
author E. R. Job
T. Ysenbaert
A. Smet
A. Van Hecke
L. Meuris
H. Kleanthous
X. Saelens
T. U. Vogel
author_facet E. R. Job
T. Ysenbaert
A. Smet
A. Van Hecke
L. Meuris
H. Kleanthous
X. Saelens
T. U. Vogel
author_sort E. R. Job
title Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
title_short Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
title_full Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
title_fullStr Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
title_full_unstemmed Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
title_sort fcγ receptors contribute to the antiviral properties of influenza virus neuraminidase-specific antibodies
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/7d9069626bfa4f5f9bd82345c4070ea2
work_keys_str_mv AT erjob fcgreceptorscontributetotheantiviralpropertiesofinfluenzavirusneuraminidasespecificantibodies
AT tysenbaert fcgreceptorscontributetotheantiviralpropertiesofinfluenzavirusneuraminidasespecificantibodies
AT asmet fcgreceptorscontributetotheantiviralpropertiesofinfluenzavirusneuraminidasespecificantibodies
AT avanhecke fcgreceptorscontributetotheantiviralpropertiesofinfluenzavirusneuraminidasespecificantibodies
AT lmeuris fcgreceptorscontributetotheantiviralpropertiesofinfluenzavirusneuraminidasespecificantibodies
AT hkleanthous fcgreceptorscontributetotheantiviralpropertiesofinfluenzavirusneuraminidasespecificantibodies
AT xsaelens fcgreceptorscontributetotheantiviralpropertiesofinfluenzavirusneuraminidasespecificantibodies
AT tuvogel fcgreceptorscontributetotheantiviralpropertiesofinfluenzavirusneuraminidasespecificantibodies
_version_ 1718427036905635840